A new concept for the production of 11C-labelled radiotracers

Background The GMP-compliant production of radiopharmaceuticals has been performed using disposable units (cassettes) with a dedicated synthesis module. To expand this plug 'n' synthesize principle to a broader scope of modules we developed a pressure controlled setup that offers an alternative to the usual stepper motor controlled rotary valves. The new concept was successfully applied to the synthesis of N-methyl-[C-11]choline, L-S-methyl-[C-11]methionine and [C-11]acetate. Results The target gas purification of cyclotron produced [C-11]CO2 and subsequent conversion to [C-11]MeI was carried out on a TRACERlab Fx C Pro module. The labelling reactions were controlled with a TRACERlab Fx FE module. With the presented modular principle we were able to produce N-methyl-[C-11]choline and L-S-methyl-[C-11]methionine by loading a reaction loop with neat N,N'-dimethylaminoethanol (DMAE) or an ethanol/water mixture of NaOH and L-homocysteine (L-HC), respectively and a subsequent reaction with [C-11]MeI. After 18 min N-methyl-[C-11]choline was isolated with 52% decay corrected yield and a radiochemical purity of > 99%. For L-S-methyl-[C-11]methionine the total reaction time was 19 min reaction, yielding 25% of pure product (> 97%). The reactor design was used as an exemplary model for the technically challenging [C-11]acetate synthesis. The disposable unit was filled with 1 mL MeMgCl (0.75 M) in tetrahydrofuran (THF) bevore [C-11]CO2 was passed through. After complete release of [C-11]CO2 the reaction mixture was quenched with water and guided through a series of ion exchangers (H+, Ag+ and OH-). The product was retained on a strong anion exchanger, washed with water and finally extracted with saline. The product mixture was acidified and degassed to separate excess [C-11]CO2 before dispensing. Under these conditions the total reaction time was 18 +/- 2 min and pure [C-11]acetate (n = 10) was isolated with a decay corrected yield of 51 +/- 5%. Conclusion Herein, we described a novel single use unit for the synthesis of carbon-11 labelled tracers for preclinical and clinical applications of N-methyl-[C-11]choline, L-S-methyl-[C-11]methionine and [C-11]acetate.

Automated summary

This study described a novel single use unit for the synthesis of carbon-11 labelled tracers for preclinical and clinical applications, including N-methyl-[C-11]choline, L-S-methyl-[C-11]methionine, and [C-11]acetate.